ZACHARY NELSON, a director at $FRSH, sold 8,433 shares of the company on 09-02-2025 for an estimated $110,809. We received data on the trade from a recent SEC filing. This was a sale of approximately 17.8% of their shares of this class of stock. Following this trade, they now own 38,870 shares of this class of $FRSH stock.
$FRSH Insider Trading Activity
$FRSH insiders have traded $FRSH stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $FRSH stock by insiders over the last 6 months:
- RATHNAGIRISH MATHRUBOOTHAM (EXECUTIVE CHAIRMAN) has made 0 purchases and 3 sales selling 130,183 shares for an estimated $2,083,637.
- ZACHARY NELSON has made 0 purchases and 5 sales selling 42,173 shares for an estimated $591,776.
- JENNIFER H TAYLOR has made 0 purchases and 7 sales selling 35,683 shares for an estimated $516,155.
- MIKA YAMAMOTO (CHIEF CUST & MARKETING OFFICER) has made 0 purchases and 7 sales selling 25,354 shares for an estimated $361,413.
- ROXANNE S AUSTIN has made 0 purchases and 3 sales selling 18,904 shares for an estimated $265,532.
- BARRY L. PADGETT has made 0 purchases and 7 sales selling 12,243 shares for an estimated $180,546.
- JOHANNA FLOWER has made 0 purchases and 2 sales selling 11,810 shares for an estimated $179,360.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$FRSH Hedge Fund Activity
We have seen 175 institutional investors add shares of $FRSH stock to their portfolio, and 167 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TPG GP A, LLC removed 4,346,855 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $61,334,124
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 2,426,030 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $36,172,107
- HOLOCENE ADVISORS, LP removed 2,425,953 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $34,230,196
- EMINENCE CAPITAL, LP added 2,074,641 shares (+39.4%) to their portfolio in Q2 2025, for an estimated $30,932,897
- NORGES BANK removed 1,873,323 shares (-52.7%) from their portfolio in Q2 2025, for an estimated $27,931,245
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 1,853,143 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $27,630,362
- SQUAREPOINT OPS LLC added 1,423,391 shares (+345.1%) to their portfolio in Q2 2025, for an estimated $21,222,759
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$FRSH Analyst Ratings
Wall Street analysts have issued reports on $FRSH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 07/30/2025
- Cantor Fitzgerald issued a "Overweight" rating on 06/03/2025
- UBS issued a "Buy" rating on 05/02/2025
- Wells Fargo issued a "Underweight" rating on 04/30/2025
- JMP Securities issued a "Market Outperform" rating on 04/30/2025
- Oppenheimer issued a "Outperform" rating on 04/09/2025
- Needham issued a "Buy" rating on 03/17/2025
To track analyst ratings and price targets for $FRSH, check out Quiver Quantitative's $FRSH forecast page.
$FRSH Price Targets
Multiple analysts have issued price targets for $FRSH recently. We have seen 10 analysts offer price targets for $FRSH in the last 6 months, with a median target of $19.5.
Here are some recent targets:
- Brent Bracelin from Piper Sandler set a target price of $25.0 on 07/30/2025
- Matthew Vanvliet from Cantor Fitzgerald set a target price of $20.0 on 06/03/2025
- Taylor McGinnis from UBS set a target price of $19.0 on 05/02/2025
- Elizabeth Porter from Morgan Stanley set a target price of $18.0 on 05/01/2025
- Nick Altmann from Scotiabank set a target price of $18.0 on 04/30/2025
- Michael Berg from Wells Fargo set a target price of $12.0 on 04/30/2025
- Patrick Walravens from JMP Securities set a target price of $27.0 on 04/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
